Platelet-cancer Crosstalk: Mechanisms and Therapeutic Implications
MetadataShow full item record
Platelets are small anucleate blood cells that are central to primary haemostasis. However, platelets are also implicated in cancer pathogenesis. This thesis showed that cancer cells promote thrombosis by activating platelets, and in turn, platelets provide cancer cells with growth factors to render cancer more aggressive and chemoresistant. The thesis demonstrated a therapeutic benefit of combined antiplatelet, ticagrelor, and chemo drugs, on cancer treatment.
Showing items related by title, author, creator and subject.
The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistanceElaskalani, Omar; Falasca, Marco; Moran, N.; Berndt, Michael; Metharom, Pat (2017)Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between ...
Walsh, T.; Metharom, Pat; Berndt, Michael (2015)Functionally, platelets are primarily recognized as key regulators of thrombosis and hemostasis. Upon vessel injury, the typically quiescent platelet interacts with subendothelial matrix to regulate platelet adhesion, ...
Pancreatic cancer-induced neutrophil extracellular traps: A potential contributor to cancer-associated thrombosisRazak, N.; Elaskalani, O.; Metharom, Pat (2017)Pancreatic cancer (PaCa) is a highly metastatic cancer, and patients are at high risk of developing venous thromboembolism (VTE). Neutrophil extracellular traps (NETs) have been associated with cancer metastasis and ...